RMD
insider transactionsRESMED INC — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-5.0K
0 buy · 5.0K sell
Net value · 30d
-$968.1K
$0 in · $968.1K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
1
0 buy · 5.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Chairman and CEO · 10b5-1
$0
5.0K sh
Own +25%
-
Sell·S
Chairman and CEO · 10b5-1
$968.1K
5.0K sh · $193.96
Own -1%
-
Exercise·M
Chairman and CEO · 10b5-1
$730.4K
5.0K sh · $146.34
Own +1%
-
Other·F
Global General Counsel
$51.2K
269 sh · $190.57
Own -3%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 8, 2026 | Michael J. Farrell KEY 10b5-1 | Exercise M | 5.0K | $0 |
| Jun 8, 2026 | Michael J. Farrell KEY 10b5-1 | Sell S | 5.0K | $968.1K |
| Jun 8, 2026 | Michael J. Farrell KEY 10b5-1 | Exercise M | 5.0K | $730.4K |
| Jun 1, 2026 | Michael J Rider | Other F | 269 | $51.2K |
About RMD insider trading
This page tracks insider transactions for RESMED INC (RMD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.